Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1200816011 | Hyoscyamine 0.15mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1213838015 | Hyoscyamine 0.15mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2153567011 | Hyoscyamine 150micrograms tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2161148014 | Hyoscyamine 150micrograms tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3490073013 | Product containing hyoscyamine 150 microgram/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3493939017 | Product containing hyoscyamine 150 microgram/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3493940015 | Hyoscyamine 150 microgram/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3568460019 | Product containing only hyoscyamine 150 microgram/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3568461015 | Product containing only hyoscyamine 150 microgram/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3679706016 | Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3679707013 | Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3679708015 | Hyoscyamine 150 microgram oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 108301001000001112 | Hyoscyamine 150 microgram/1 each oral tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Is a | Product containing hyoscyamine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Is a | Product containing hyoscyamine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Has active ingredient | Hyoscyamine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Has active ingredient | Hyoscyamine | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Has basis of strength substance | Hyoscyamine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Has precise active ingredient | Hyoscyamine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hyoscyamine 150 microgram/1 each conventional release oral tablet | Is a | Product containing only hyoscyamine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR